We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi has agreed to pay $3.7 billion for San Francisco-based Principia Biopharma, giving the French drugmaker full control of a potential multiple sclerosis drug. Read More
The U.S. government has chosen distribution giant McKesson as a “central distributor” of COVID-19 vaccines and supplies needed to administer them once an approval or emergency authorization is granted. Read More
To produce components needed for their COVID-19 vaccine candidates, Novavax has enlisted support from a South Korean biotech, while Johnson & Johnson has agreed to work with an Indian biopharma company. Read More